The Effect of Walking on Cardiovascular Risk

Ulster University

Status

Completed

Conditions

Sedentariness

Treatments

Behavioral: Walking 45 mins 2x p.w.

Study type

Interventional

Funder types

Other

Identifiers

NCT00284479

Murtagh/Murphy 2004

Details and patient eligibility

About

The purpose of this study was to investigate the effects of an 8 week program of walking for 45 minutes, twice a week, on fitness, body composition , blood pressure and blood markers of cardiovascular risk. We hypothesised that this 90 minutes of walking per week would result in measurable increases in fitness and reductions in body fat, resting blood pressure and improved blood lipid profiles.

Full description

Current physical activity guidelines suggest that every adult should accumulate 30 minutes or more of moderate intensity physical activity on most days of the week. However, compliance with these guidelines requires considerable commitment in terms of time spent exercising per week (> 150 minutes) and this may deter individuals from starting an exercise programme. Accordingly, randomised controlled trials are needed to evaluate the effects of smaller volumes of exercise on health.

37 civil servants (24 women) aged 41.5 + 9.3 years, were randomly assigned to either two 45 minute walks per week (walking group) or no training (control group). Aerobic fitness, body composition, blood pressure (BP), CRP and lipoprotein variables were measured at baseline and following 8 weeks. Steps counts were measured at baseline and during weeks 4 and 8 of the intervention

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Member of staff at the Northern Ireland Civil Service

Exclusion criteria

Physically active (defined as compliance with current physical activity guidelines (Pate, 1995), age > 65 years, resting BP > 159/99 mm Hg, total cholesterol > 6.2 mmol•L-1, fasting blood glucose > 7.0 mmol•L-1, body mass index (BMI) > 34.9 kg•m-2, current cigarette smokers, individuals with cardiovascular, pulmonary or metabolic disease, pain or discomfort in the chest, dizziness or heart murmur.

individuals taking medication known to interfere with lipid metabolism, females who were pregnant or planning to become pregnant in the following five months